These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 7613276)

  • 21. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
    Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
    Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Trindade E; Menon D; Topfer LA; Coloma C
    CMAJ; 1998 Nov; 159(10):1245-52. PubMed ID: 9861221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants and the risk of falls among nursing home residents.
    Thapa PB; Gideon P; Cost TW; Milam AB; Ray WA
    N Engl J Med; 1998 Sep; 339(13):875-82. PubMed ID: 9744971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.
    Kendrick T; Peveler R; Longworth L; Baldwin D; Moore M; Chatwin J; Thornett A; Goddard J; Campbell M; Smith H; Buxton M; Thompson C
    Br J Psychiatry; 2006 Apr; 188():337-45. PubMed ID: 16582060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amitriptyline for depression.
    Guaiana G; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004186. PubMed ID: 17636748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.
    Crown WH
    Acta Psychiatr Scand Suppl; 2000; 403():62-6. PubMed ID: 11019937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.
    Freemantle N; House A; Song F; Mason JM; Sheldon TA
    BMJ; 1994 Jul; 309(6949):249-53. PubMed ID: 7832842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of severe depression with the selective serotonin reuptake inhibitors.
    Schatzberg AF
    Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
    Peet M
    Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
    Berndt ER; Bhattacharjya A; Mishol DN; Arcelus A; Lasky T
    J Ment Health Policy Econ; 2002 Mar; 5(1):3-19. PubMed ID: 12529566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tricyclic antidepressants and headaches: systematic review and meta-analysis.
    Jackson JL; Shimeall W; Sessums L; Dezee KJ; Becher D; Diemer M; Berbano E; O'Malley PG
    BMJ; 2010 Oct; 341():c5222. PubMed ID: 20961988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
    Su KP; Tang CH; Chang HC; Chiu WC; Lu N; Huang KC
    Int Clin Psychopharmacol; 2019 Jul; 34(4):170-178. PubMed ID: 30964763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.
    Barbui C; Hotopf M
    Br J Psychiatry; 2001 Feb; 178():129-44. PubMed ID: 11157426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of accidents in evaluating the cost of SSRIs: a review.
    Hale AS
    Int Clin Psychopharmacol; 1994 Sep; 9(3):195-201. PubMed ID: 7814829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.